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Abstract
We report the first case of extended-spectrum beta-lactamase producing E. coli community-acquired meningitis
complicated with multiple aortic mycotic aneurysms. Because of the acute aneurysm expansion with possible
impending rupture on 2 abdominal CT scan, the patient underwent prompt vascular surgery and broad spectrum
antibiotic therapy but he died of a hemorrhagic shock. Extended-spectrum beta-lactamase producing E. coli was
identified from both blood and cerebrospinal fluid culture before vascular treatment. The present case report does
not however change the guidelines of Gram negative bacteria meningitis in adults.
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Introduction
Adult community-acquired meningitis due to E. coli is a
rare entity. It generally occurs in patients with compro-
mised immune status or cirrhosis. When direct examina-
tion of the cerebrospinal fluid (CSF) shows the presence of
Gram negative bacilli (GNB), current guidelines recom-
mend the use of a 3rd generation cephalosporin (cefotax-
ime or ceftriaxone) [1,2]. We herein report the first case of
extended-spectrum beta-lactamase (ESBL) producing
E. coli community-acquired meningitis complicated with
multiple aortic mycotic aneurysms.
Observation
In September 2010, a 59-year-old patient with a history
of chronic alcohol and tobacco consumption was
admitted to the emergency unit for consciousness disor-
ders and fever. Two days before his admission, the
patient had presented headache and nausea.
At admission (09/28), physical examination revealed a
frank meningeal irritation, consciousness disorders with a
Glasgow Coma Scale (GCS) of 12. The patient’s hemody-
namic status was stable and, no other physical abnormality
was found. WBC count was 3.85 G/L; hemoglobin rate,
14.6 g/dl; platelets count, 64 G/L; C-reactive protein rate
(CRP), 292 mg/L; procalcitonin rate, 21.9 ng/ml and pro-
thrombine rate, 44%. The renal and hepatic functions
were normal. CSF examination showed 440 cells/mm3,
(neutrophils 62%, lymphocytes 29%) with a glucose and
protein rate at 0.01 mmol/l and 10.35 g/l, respectively.
The chest X-ray, electrocardiogram and cerebral computer
tomography (CT) scan were normal. The patient was
transferred to the intensive care unit few hours after his
admission because of a rapid deterioration of conscious-
ness (GCS 6) and the occurrence of septic shock. Mechan-
ical ventilation, volume resuscitation, hydrocortisone
hemisuccinate, vasopressors, platelets transfusion and
intravenous empirical broad spectrum antibiotic therapy
were administered. The patient received cefotaxime 18 g/
24 h, amoxicillin 12 g/24 h and gentamicin 460 mg/24 h.
Both CSF and blood culture yielded an ESBL producing
E. coli resistant to cefalotin (MIC ≥ 64), cefotaxime (MIC
≥ 64), ceftriaxone (MIC ≥ 64), cefixime (MIC2), intermedi-
ate to cefepim (MIC 2) and ceftazidime (MIC 2), and sus-
ceptible to cefoxitin (MIC ≤ 4), ertapenem (MIC ≤ 0.5),
meropenem (MIC ≤ 0.5), imipenem (MIC ≤ 1), gentamicin
(MIC ≤ 1), ofloxacin (MIC ≤ 0.12)and ciprofloxacin (MIC
≤ 0.25). Cefotaxime was switched to meropenem (6 g per
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day) combined with ciprofloxacin (1.2 g per day). No
abscess was found on brain MRI and thoraco-abdominal
CT scan. Meropenem-ciprofloxacin therapy was discontin-
ued after 21 days of treatment (10/18). The patient’s con-
dition improved slowly, allowing his extubation after 20
days of mechanical ventilation (10/18). Abnormal CRP
rate (> 120 mg/l) persisted at this moment. One week
after extubation (10/25), the patient was transferred to the
department of infectious diseases. At the admission, physi-
cal exam showed confusion with slow ideation. There was
no abnormality on cardiac, pulmonary and urological
examination except a moderate abdominal painful at pal-
pation. Ten days after stopping the antimicrobial treat-
ment (10/28), the laboratory tests showed a persisting
elevated rate of CRP (212 mg/L) and a elevated white
blood cell count to 23.6 G/L. Thoracic and abdomi-nopel-
vic CT scan were performed which showed multiple
mycotic aneurysms of the infra-renal aorta, the aorto-iliac
bifurcation and the primitive iliac artery, an inferior vena
cava thrombosis, a complete right kidney infarct and a
delay in left kidney perfusion. (Figure 1 and 2). The trans-
thoracic echocardiography showed no sign of infectious
endocarditis. The patient was transfered to the operating
room for aorto-iliac by-pass. No bacteria growth on new
bacterial samples but there was taken after antibiotic
treatment was started. Unfortunately, the patient died dur-
ing the surgery of a hemorrhagic shock.
Discussion
Community-acquired meningitis in adults due to E. coli
is a rare entity. The main risk factors are alcoholism,
cirrhosis, neoplasic diseases, diabetes mellitus, and treat-
ment with immunosuppressive agents [3-7]. Others
cases occur frequently in neurosurgery and are usually
associated with multi-drug resistant strains [8-11]. In
our observation, the patient had no risk factors except a
chronic alcoholism and perhaps his dog as animal pet.
In Europe, there is an increasing in 3rd generation
cephalosporin resistant E. coli isolates in both hospital
setting and the community. CTX-M ESBL is the most
common genetic support of resistance in these strains
[12]. In our case report, we suspected this mechanism.
The spread of E. coli producing ESBL is now well- iden-
tified [13].
Blood stream infections due to E. coli in adults are
often related to underlying urinary or bilary tract or
other intra-abdominal infections. Vascular infections
and meningitis due to E. coli are exceedingly rare and
few cases isolated have been reported [14-16]. Diabetes
mellitus, previous fluoroquinolone use, recurrent urinary
Figure 1 multiple mycotic aneurysms of the infra-renal aorta.
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tract infection, previous hospital admission and older
age in male patients have been identified as risk factors
for infection of ESBL-producing E. coli [17]. Recently,
Ewers and al. suggested the possibility of inter-species
transmission of multiresistant strains of E. coli from
human to animal and vice versa [18].
The current guidelines for the management of gram
negative bacilli (GNB) related meningitis are well codified
and recommend the use of a 3rd generation cephalospor-
ins ± gentamicin. Alternative therapies are Cefepime,
meropenem, aztreonam, fluoroquinolone, and trimetho-
prim-sulfamethoxazole [1,2]. In our case report, merope-
nem (in association with ciprofloxacin) was used because
of the lower risk of seizures compared to imipenem
[19,20]. Mortality associated with GNB related meningitis
varied from 25 to 100% [7,21]. Lu et al. identified several
risk factors for mortality associated to GNB related
meningitis: inappropriate initial treatment, septic shock,
initial level of consciousness, hyperosmolar hyperglyce-
mic coma, disseminated intravascular coagulation, high
CSF lactate levels and leucocytosis. In the multiple logis-
tic regression analysis, only appropriate antimicrobial
therapy and septic shock were strongly associated with
mortality even after adjusting for other potentially con-
founding factors [21]. Inappropriate treatment and septic
shock were initially present in our patient. The presence
of a concomitant aortic mycotic aneurysm was an addi-
tional factor of mortality.
Only two cases of mycotic aneurysm in patient present-
ing initially bacterial meningitis have been reported
[22,23]. The first case is a 65-year old woman with rup-
tured mycotic aneurysm in a patient with pneumococcal
meningitis, who died on week later. The second case is a
57 year-old man with a history of CFS fistula and multi-
ple neurosurgical treatment, who developed meningitis
complicated with endocarditis and thoracic aortic infec-
tion. No bacteria were identified in this second case. The
patient was successfully treated with endovascular pros-
thesis. In the present case report, multiple mycotic
aneurysms were suspected because of the sustained bac-
teremia, the atypical and multiple foci of vascular infec-
tion, the normality of the first abdominal CT scan and
the rapid evolution of aneurysm. the aortic involvement
may be the result of infection of the aortic wall.
Conclusion
The present case report highlights the risk of meningitis
due to ESBL producing E. coli in a patient with appar-
ently no risk factor for this infection with this type of
resistant bacilli. This unique observation does not
Figure 2 multiple mycotic aneurysms of the infra-renal aorta and inferior vena cava thrombosis, incomplete right kidney infarct and a
delay in left kidney perfusion.
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provide, however to modify the current guidelines for
the treatment of community acquired meningitis in
adults.
Consent
Written informed consent was obtained from the
patient’s family for publication of this case report and
accompanying images.
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